Skip to main content

The Truth and Fallacies of Recombinant Endotoxin Assays

OVERVIEW

The comparability and equivalence of recombinant Factor C (rFC) to LAL has been proven with over 10 peer-reviewed studies by government and pharmaceutical facilities. Some articles and papers with limited scientific proof have been recently published, attempting to raise doubt with users and authorities regarding the use of these recombinant methods. Because science matters, we invite you to participate in this webinar series to take a look at the truths and fallacies of recombinant endotoxin assays. Our experts will be happy to answer your questions.

 

SPEAKERS

Brendan Tindall
Global Solution Manager – ENDONEXT
bioMérieux

ACCESS TO THE WEBINAR REPLAY →

  

Related Products

Dairy products on display

ENDONEXT™

ENDONEXT™ endotoxin detection assays are ushering in a new era of smarter, more sustainable pharmaceutical quality control.

Learn More

ENDOXPERTS™

ENDOXPERTS™ Endotoxin Services by bioMérieux provide routine testing and feasibility studies as well as specialized services for analytical issues such as LER. Our work for leading pharmaceutical companies has resulted in validated methods for LER, fulfilling regulatory requirements. 

Learn more

ENDOZYME® II GO

By significantly reducing hands-on time, ENDOZYME® II GO not only makes your lab more efficient — it reduces the risk of invalid results and reduces laboratory waste by eliminating manual preparation steps that are prone to handling errors.

Learn more